PL2612926T3 - Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo - Google Patents
Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivoInfo
- Publication number
- PL2612926T3 PL2612926T3 PL13161985T PL13161985T PL2612926T3 PL 2612926 T3 PL2612926 T3 PL 2612926T3 PL 13161985 T PL13161985 T PL 13161985T PL 13161985 T PL13161985 T PL 13161985T PL 2612926 T3 PL2612926 T3 PL 2612926T3
- Authority
- PL
- Poland
- Prior art keywords
- mirna
- detection
- methods
- cell death
- vivo cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96587107P | 2007-08-22 | 2007-08-22 | |
EP13161985.0A EP2612926B1 (en) | 2007-08-22 | 2008-08-22 | Methods of using mirna for detection of in vivo cell death |
EP08795523.3A EP2195450B2 (en) | 2007-08-22 | 2008-08-22 | Methods of using mirna for detection of in vivo cell death |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2612926T3 true PL2612926T3 (pl) | 2018-07-31 |
Family
ID=40378881
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13161985T PL2612926T3 (pl) | 2007-08-22 | 2008-08-22 | Metody wykorzystania mirna do wykrywania śmierci komórkowej in vivo |
PL08795523T PL2195450T3 (pl) | 2007-08-22 | 2008-08-22 | Sposób zastosowania miRNA do wykrywania in vivo śmierci komórki |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08795523T PL2195450T3 (pl) | 2007-08-22 | 2008-08-22 | Sposób zastosowania miRNA do wykrywania in vivo śmierci komórki |
Country Status (17)
Country | Link |
---|---|
US (4) | US8486626B2 (pl) |
EP (2) | EP2195450B2 (pl) |
JP (1) | JP5416110B2 (pl) |
CN (2) | CN105400868B (pl) |
AU (2) | AU2008289447B2 (pl) |
CA (1) | CA2696403C (pl) |
CY (1) | CY1114111T1 (pl) |
DK (2) | DK2612926T3 (pl) |
ES (2) | ES2660785T3 (pl) |
HK (1) | HK1218767A1 (pl) |
HR (1) | HRP20130618T1 (pl) |
HU (1) | HUE019019T5 (pl) |
NO (1) | NO2612926T3 (pl) |
PL (2) | PL2612926T3 (pl) |
PT (2) | PT2195450E (pl) |
TR (1) | TR201802758T4 (pl) |
WO (1) | WO2009025852A2 (pl) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110111976A1 (en) * | 2008-04-25 | 2011-05-12 | Merck Sharp & Dohme Corp. | Microrna biomarkers of tissue injury |
WO2010004562A2 (en) * | 2008-07-09 | 2010-01-14 | Rosetta Genomics Ltd. | Methods and compositions for detecting colorectal cancer |
ES2595489T3 (es) * | 2008-07-18 | 2016-12-30 | Trovagene, Inc. | Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR |
US20120034608A1 (en) * | 2009-04-14 | 2012-02-09 | Merck Sharp & Dohme Corp. | Microrna as a biomarker of pancreatic islet beta-cell engagement |
WO2011006119A2 (en) | 2009-07-09 | 2011-01-13 | The Scripps Research Institute | Gene expression profiles associated with chronic allograft nephropathy |
WO2011057003A2 (en) | 2009-11-04 | 2011-05-12 | Samuil Umansky | Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
DK2496720T3 (da) | 2009-11-06 | 2020-09-28 | Univ Leland Stanford Junior | Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter |
EP2569453B1 (en) * | 2010-05-14 | 2015-12-16 | Fluidigm Corporation | Nucleic acid isolation methods |
EP3133147B1 (en) | 2011-04-18 | 2019-03-27 | DiamiR, LLC | Universal screening test based on mirna (ust) |
CN102188719B (zh) * | 2011-05-12 | 2012-12-19 | 南方医科大学 | EB病毒miR-BART3反义寡聚核苷酸在制备治疗鼻咽癌的药物中的应用 |
JP6154809B2 (ja) * | 2011-06-27 | 2017-06-28 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アルツハイマー病を示すマイクロrnaバイオマーカー |
US20130040303A1 (en) * | 2011-08-08 | 2013-02-14 | Eugenia Wang | Biomarker for Alzheimer's Disease and/or Mild Cognitive Impairment, and Use Thereof |
CA3069089A1 (en) * | 2011-09-22 | 2013-03-28 | Lineage Biosciences, Inc. | Compositions and methods for analyzing heterogeneous samples |
ITRM20110685A1 (it) | 2011-12-23 | 2013-06-24 | Internat Ct For Genetic En Gineering And | Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci |
US20130252835A1 (en) | 2012-01-27 | 2013-09-26 | Lian Chye Winston Koh | Methods for profiling and quantitating cell-free rna |
US20140087964A1 (en) * | 2012-09-24 | 2014-03-27 | University Of Virginia Patent Foundation | Compositions and methods for detecting aberrant regulation, expression, and levels of hgh |
EP2733220B1 (en) * | 2012-11-16 | 2017-10-18 | Siemens Aktiengesellschaft | Novel miRNA as a diagnostic marker for Alzheimer's Disease |
EP2733219B1 (en) | 2012-11-16 | 2017-09-20 | Siemens Aktiengesellschaft | Diagnostic miRNA markers for Alzheimer |
US10011873B2 (en) | 2012-11-16 | 2018-07-03 | Universitat Des Saarlandes | Diagnostic miRNA markers for Parkinson disease |
CN103045596A (zh) * | 2012-12-20 | 2013-04-17 | 徐勇 | 唐氏综合征21号染色体相关miRNA、基因、筛选方法和应用 |
CN103045736B (zh) * | 2012-12-20 | 2014-09-17 | 徐勇 | 唐氏综合征21号染色体miRNA差异表达图谱模型、构建方法及应用 |
EP2759602A1 (en) | 2013-01-25 | 2014-07-30 | Charité - Universitätsmedizin Berlin | Non-invasive prenatal genetic diagnostic methods |
CN114107458A (zh) | 2013-03-15 | 2022-03-01 | 血统生物科学公司 | 测序免疫组库的方法 |
AU2014348273A1 (en) | 2013-11-18 | 2016-06-09 | Diamir, Llc | Methods of using mIRNAs from bodily fluids for detection and monitoring of Parkinson's disease (PD) |
US11104951B2 (en) | 2014-05-22 | 2021-08-31 | The Scripps Research Institute | Molecular signatures for distinguishing liver transplant rejections or injuries |
US10443100B2 (en) | 2014-05-22 | 2019-10-15 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
TWI727156B (zh) | 2014-07-18 | 2021-05-11 | 香港中文大學 | Dna混合物中之組織甲基化模式分析 |
JP6873921B2 (ja) | 2015-05-18 | 2021-05-19 | カリウス・インコーポレイテッド | 核酸の集団を濃縮するための組成物および方法 |
US10428391B2 (en) | 2015-07-27 | 2019-10-01 | The Johns Hopkins University | Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods |
CN108026570A (zh) * | 2015-09-11 | 2018-05-11 | 康宁股份有限公司 | 从血液样品中纯化核酸的组合物和方法 |
US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
EP3433381A4 (en) | 2016-03-21 | 2019-10-23 | Diamir, LLC | METHOD FOR USE OF MIRNAS FROM BODY FLUIDS FOR THE DETECTION AND DIFFERENTIATION OF NEURODEGENATIVE DISEASES |
WO2018045359A1 (en) * | 2016-09-02 | 2018-03-08 | Karius, Inc. | Detection and treatment of infection during pregnancy |
EP3538095A4 (en) | 2016-11-14 | 2020-06-17 | Berg LLC | METHOD FOR TREATING MORBUS PARKINSON |
WO2018099418A1 (en) | 2016-11-30 | 2018-06-07 | The Chinese University Of Hong Kong | Analysis of cell-free dna in urine and other samples |
US10907211B1 (en) | 2017-02-16 | 2021-02-02 | Quantgene Inc. | Methods and compositions for detecting cancer biomarkers in bodily fluids |
US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
AU2020221278A1 (en) | 2019-02-14 | 2021-08-05 | Mirvie, Inc. | Methods and systems for determining a pregnancy-related state of a subject |
EP4052650A4 (en) | 2019-10-29 | 2023-12-06 | National Cerebral and Cardiovascular Center | SYSTEM TO SUPPORT THE TREATMENT OF STROKE |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856088A (en) | 1989-07-11 | 1999-01-05 | Gen-Probe Incorporated | Detection of human immunodeficiency virus type 1 |
US5168039A (en) | 1990-09-28 | 1992-12-01 | The Board Of Trustees Of The University Of Arkansas | Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis |
US6020124A (en) | 1992-04-27 | 2000-02-01 | Trustees Of Dartmouth College | Detection of soluble gene sequences in biological fluids |
ZA945278B (en) | 1993-07-20 | 1996-01-19 | Boehringer Mannheim Gmbh | Melanoma-inhibiting protein |
WO1995004140A1 (en) | 1993-07-28 | 1995-02-09 | Akzo Nobel N.V. | Process for isolating nucleic acid from gram positive microorganisms |
WO1995006652A1 (en) | 1993-08-30 | 1995-03-09 | Promega Corporation | Nucleic acid purification compositions and methods |
US5631130A (en) | 1994-05-13 | 1997-05-20 | Abbott Laboratories | Materials and methods for the detection of Mycobacterium tuberculosis |
ES2217280T3 (es) | 1994-06-09 | 2004-11-01 | Innogenetics N.V. | Metodo para la deteccion del espectro de resistencia antibiotica de especies de microbacterias. |
US5731150A (en) | 1995-11-01 | 1998-03-24 | Chiron Diagnostic Corporation | IS6110 based molecular detection of mycobacterium tuberculosis |
US6027945A (en) | 1997-01-21 | 2000-02-22 | Promega Corporation | Methods of isolating biological target materials using silica magnetic particles |
US20020119478A1 (en) | 1997-05-30 | 2002-08-29 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
US6492144B1 (en) | 1997-05-30 | 2002-12-10 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
DK0920539T3 (da) | 1997-05-30 | 2006-07-24 | Xenomics | Fremgangsmåder til detektion af nukleinsyresekvenser i urin |
US5962665A (en) | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US20060204989A1 (en) † | 1998-09-22 | 2006-09-14 | Kopreski Michael S | Comparative analysis of extracellular RNA species |
US7196183B2 (en) | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
US20040053264A1 (en) | 2002-02-01 | 2004-03-18 | Park Sung Sup | Clinical panel assay using DNA chips |
AU2005250432B2 (en) * | 2004-05-28 | 2011-09-15 | Asuragen, Inc. | Methods and compositions involving microRNA |
ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
ITRM20050067A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine. |
CA2597948A1 (en) | 2005-02-17 | 2006-08-24 | Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani | Compositions and methods for detecting viral specific nucleic acids in urine |
EP1885877A2 (en) | 2005-02-17 | 2008-02-13 | Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS | Compositions and methods for detecting pathogen specific nucleic acids in urine |
US7914982B2 (en) | 2005-02-17 | 2011-03-29 | Trovagene, Inc. | Methods for detecting pathogen specific nucleic acids in urine |
US20060292616A1 (en) * | 2005-06-23 | 2006-12-28 | U.S. Genomics, Inc. | Single molecule miRNA-based disease diagnostic methods |
DE102005059315A1 (de) * | 2005-12-09 | 2007-06-14 | Qiagen Gmbh | Verfahren zur Anreicherung von kurzkettigen Nukleinsäuren |
US20070202511A1 (en) * | 2006-02-28 | 2007-08-30 | Sigma-Aldrich Co. | Methods and compositions for the rapid isolation of small RNA molecules |
ES2595489T3 (es) | 2008-07-18 | 2016-12-30 | Trovagene, Inc. | Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR |
-
2008
- 2008-08-22 CN CN201510649676.8A patent/CN105400868B/zh not_active Expired - Fee Related
- 2008-08-22 CA CA2696403A patent/CA2696403C/en not_active Expired - Fee Related
- 2008-08-22 EP EP08795523.3A patent/EP2195450B2/en not_active Not-in-force
- 2008-08-22 HU HUE08795523A patent/HUE019019T5/en unknown
- 2008-08-22 PL PL13161985T patent/PL2612926T3/pl unknown
- 2008-08-22 JP JP2010521887A patent/JP5416110B2/ja not_active Expired - Fee Related
- 2008-08-22 NO NO13161985A patent/NO2612926T3/no unknown
- 2008-08-22 PT PT87955233T patent/PT2195450E/pt unknown
- 2008-08-22 EP EP13161985.0A patent/EP2612926B1/en active Active
- 2008-08-22 TR TR2018/02758T patent/TR201802758T4/tr unknown
- 2008-08-22 PT PT131619850T patent/PT2612926T/pt unknown
- 2008-08-22 US US12/229,378 patent/US8486626B2/en not_active Expired - Fee Related
- 2008-08-22 DK DK13161985.0T patent/DK2612926T3/en active
- 2008-08-22 ES ES13161985.0T patent/ES2660785T3/es active Active
- 2008-08-22 ES ES08795523.3T patent/ES2415245T5/es active Active
- 2008-08-22 DK DK08795523.3T patent/DK2195450T4/en active
- 2008-08-22 WO PCT/US2008/009991 patent/WO2009025852A2/en active Application Filing
- 2008-08-22 CN CN200880113585.0A patent/CN101861399B/zh not_active Expired - Fee Related
- 2008-08-22 PL PL08795523T patent/PL2195450T3/pl unknown
- 2008-08-22 AU AU2008289447A patent/AU2008289447B2/en not_active Ceased
-
2013
- 2013-07-02 HR HRP20130618AT patent/HRP20130618T1/hr unknown
- 2013-07-03 CY CY20131100546T patent/CY1114111T1/el unknown
- 2013-07-16 US US13/942,706 patent/US20150197805A1/en not_active Abandoned
-
2014
- 2014-08-11 AU AU2014210676A patent/AU2014210676B2/en not_active Ceased
-
2016
- 2016-06-13 HK HK16106720.6A patent/HK1218767A1/zh unknown
-
2017
- 2017-01-06 US US15/400,157 patent/US20180135126A1/en not_active Abandoned
-
2018
- 2018-09-21 US US16/138,338 patent/US20200283851A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1218767A1 (zh) | 使用 檢測體內細胞死亡情況的方法 | |
IL276146A (en) | Laboratory methods for increasing the vitality of the cells of the immune system | |
EP2376920A4 (en) | METHOD FOR DETECTING CHANGES IN CELLS | |
HK1221266A1 (zh) | 單細胞中的基因表達分析 | |
EP2391711A4 (en) | NEW CELL LINES AND METHOD | |
ZA201008391B (en) | Pluripotent cells | |
EP2424877A4 (en) | SUPERCHARGED PROTEINS FOR CELL PENETRATION | |
EP2297182A4 (en) | SUPER-LOADED PROTEINS FOR CELL PENETRATION | |
EP2430446A4 (en) | METHOD AND COMPOSITIONS FOR DETECTING ANALYTES | |
EP2321426A4 (en) | COMPOSITIONS FOR DETECTING CELL DEATH AND USE METHOD | |
SG10201405455UA (en) | Cells and methods for obtaining them | |
HK1152321A1 (en) | Cell lines expressing gabaa and methods of using them | |
EP2334814A4 (en) | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA INJURIES | |
EP2493494A4 (en) | METHODS AND NECESSARY TO PREVENT HYPOGLYCEMIA | |
GB0801479D0 (en) | Improvements to methods of in field analysis | |
EP2483391A4 (en) | PROCESS AND KITS FOR THE RELEASE OF CELLS | |
EP2377947A4 (en) | METHOD FOR DETECTING CANCER CELLS IN A BLOOD TEST | |
GB0817990D0 (en) | Cell culture vessel | |
EP2121042A4 (en) | COMPOUNDS AND METHOD FOR THE DETECTION OF CELLS | |
GB0921712D0 (en) | Methods of detecting DNA damage | |
TWI369495B (en) | Cell detecting method | |
GB0919520D0 (en) | Quantifying cell death | |
EP2298879A4 (en) | METHOD FOR DNA AMPLIFICATION IN THE CELL | |
SI2195450T1 (sl) | Postopki za uporabo miRNA za detekcijo celične smrti in vivo | |
EP2478113A4 (en) | COMPOSITIONS AND METHODS FOR EVALUATING BIOLUMINESCENCE IN VIVO |